Rachel Lewis Joao Grando
GENUI has tapped Rothschild to explore a sale of Swiss diagnostic laboratory group labor team w just a year after acquiring the company, according to two sources familiar with the situation.
Auri Aittokallio Kasper Viio Gustav Hoejmark-Jensen
Vaaka Partners is preparing to launch a sale process to exit portfolio business Unisport, a pan-Nordic sports facility surfaces and equipment company, three sources familiar with the situation said.
Mike Didymus
CVC Capital Partners is reportedly looking to sell its stake in the toll road unit of China's Road King Infrastructure in a deal which could value the business at up to $3bn. The post CVC
Rachel Lewis
Holland Capital has sold Dutch dermatology platform Mauritskliniek to Ufenau-backed Corius, nine months after an exit to Triton-owned Bergman was blocked by the competition authorities.
Mike Didymus
Carlyle has ended its 15-year ownership of aircraft engine and gas turbine specialist Sequa through a sale to fellow private equity house Veritas Capital. The post Carlyle exits 15-year investment in Sequa through sale to
Harriet Matthews
Against a backdrop of shifting asset allocation dynamics, US interest in Europe and fluctuating valuations, 2023 could be a strong fundraising year for private markets, Marc Syz, managing partner at alternative asset manager Syz Capital,
Mike Didymus
Bain Capital is reportedly prepping a sale of Japanese human resources software business Works Human Intelligence which could value it at up to $2bn. The post Bain Capital said to prep sale of Japan’s Works
Rachel Lewis
Iberian private equity firm Magnum Capital has exited Spanish ophthalmology clinic chain Miranza in an off-market transaction that values the company at EUR 250m.
Emily Lai
London-based PE firm Duke Street has agreed to sell German medical tech business Medi-Globe Technologies to FTSE 100 listed DCC for £213m. The post Duke Street agrees £213m deal to exit German medical tech business
Mergermarket
Partner in Pet Food (PPF), a Hungary-based pet food manufacturer owned by Cinven, could come up for sale next year, two sources familiar with the situation said.
Emily Lai
Carlyle is considering the final rounds of bids for its $1bn-targeting AmbioPharm exit from fellow buyout houses Fountainvest Capital Partners, TPG and Warburg Pincus, Reuters reported quoting sources. The post Fountainvest, TPG, WP among final
Rachel Lewis Gustav Hoejmark-Jensen Jonathan Klonowski
So far in 2022, GP-led secondary deals have been holding fast as exits involving special purpose acquisition companies (SPACs) have faded from fashion. As GPs and LPs continue to seek liquidity in a challenging exit
Rachel Lewis
Adelis Equity Partners has sold its majority stake in Nordic dental labs group Nordentic to peer Corus, backed by CareVentures and Quadrum Capital.
Mike Didymus
Inflexion has scored a strong exit of testing and inspection business Phenna through a £1bn-plus sale to fellow private equity investor Oakley Capital. The post Inflexion’s Phenna valued at over £1bn through sale to Oakley
Mike Didymus
Align Capital Partners has scored a rapid exit of accounting and tax services business WilliamsMarston after just two years in its portfolio. The post After two years of bolt-ons, Align Capital has sold WilliamsMarston to
Patrick Costello
German sponsor NORD Holding has agreed to acquire a majority stake in Germany-based Heizkurier, a provider of mobile heating and cooling units, from sponsor Odewald KMU.
Rachel Lewis
Private equity firm CataCap has exited logistics software developer Lyngsoe Systems to Accent Equity.
Mike Didymus
Venture capital firms are always quick to blow their trumpet announcing the latest impressive valuations of their portfolio businesses - but such largesse in investments rounds could be about to come back and bite them.
Mike Didymus
Global buyout giant Apollo has bought into GI Alliance, the largest independent gastroenterology practice in the US, at a $2.2bn valuation. The post Apollo buys into US gastroenterology major GI Alliance at $2.2bn valuation first
Mike Didymus
Dallas-based buyout house Pharos Capital has sold its stake in infectious disease and parasite diagnostic test maker TechLab. The post Pharos exits six-year investment in infectious disease testing specialist TechLab first appeared on AltAssets Private
